Sector Watch: Healthcare - Oct 04 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $117.88 -3.38 -2.79% | XBI: $91.84 -3.06 -3.22% | Updated Oct 04, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| PRTK Paratek Pharmaceuticals $359.5M |
11.33+1.29 5.2 M 9.1x |
13% | ||
| AMPE Ampio Pharmaceuticals $61.8M |
0.58+0.06 2.9 M 1.7x |
12% | ||
| AMRN52WH Amarin $6.7B |
20.29+2.09 51.1 M 2.6x |
11% | ||
| INCR52WH INC Research Holdings $261.3M |
323.00+32.80 2.9 M |
11% | ||
| CSBR Champions Oncology $170.5M |
15.27+1.47 510.9 K |
11% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals $1.3B |
15.33-3.23 19.1 M 7.7x |
-17% | ||
| MNK Mallinckrodt $2.1B |
25.73-5.40 6.7 M 3.1x |
-17% | ||
| ASMB52WL Assembly Biosciences $710.7M |
27.93-4.01 613.8 K 3.2x |
-13% | ||
| PTI Proteostasis Therapeutics $80.7M |
2.20-0.31 306.0 K 2.5x |
-12% | ||
| TLGT Teligent $173.5M |
3.24-0.45 653.7 K 2.6x |
-12% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Ampio Provides Corporate Update [prnewswire.com]Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection [prnewswire.com]
Paratek Pharmaceuticals, Inc. to Host Investor Day on October 23, 2018 [globenewswire.com]
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018 [prnewswire.com]
Emerson Names Lori Lee to Board of Directors | Business Wire [businesswire.com]
Paratek Announces FDA Approval of NUZYRA? (Omadacycline) [globenewswire.com]
Emerson Names Lori Lee to Board of Directors [businesswire.com]
AMPE ALERT: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm ? AMPE [globenewswire.com]
Teligent, Inc. Announces FDA Approval of Fluocinonide Ointment USP, 0.05% [globenewswire.com]
FDA Approves SEYSARA? (Sarecycline) for the Treatment of Moderate to Severe Acne [globenewswire.com]
Assembly Biosciences Announces Oral Presentation at 2018 AASLD [globenewswire.com]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TSLA, AMPE, NVRO, CBS and SKX [globenewswire.com]
Colorectal Cancer - Pipeline Review, H1 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm [globenewswire.com]
AMPIO ALERT: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important October 24, 2018 Deadline in First Filed Case Commenced by Firm ? AMPE [globenewswire.com]
CLASS ACTION UPDATE for TSLA, AMPE and SBGI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
Systemic Sclerosis (Scleroderma) Pipeline Review, H2 2018 - Therapeutic Assessment of 43 Companies & Drug Profiles - ResearchAndMarkets.com | Business Wire [businesswire.com]
Community Acquired Pneumonia Pipeline Review, H2 2018 - Therapeutic Assessment of 15 Companies & Drug Profiles - ResearchAndMarkets.com | Business Wire [businesswire.com]
Hepatic Encephalopathy Pipeline Review, H2 2018 - Therapeutic Assessment of 8 Companies - ResearchAndMarkets.com | Business Wire [businesswire.com]
Proteostasis Therapeutics to Present at the Cantor Global Healthcare Conference | Business & Finance | heraldchronicle.com [prnewswire.com]
Amarin to Present at the Cantor Global Healthcare Conference Nasdaq:AMRN [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TSLA, PDD, AMPE, SBGI and SKX [globenewswire.com]
Constipation Pipeline Review, H2 2018 - Therapeutic Assessment of 17 Companies & Drug Profiles - ResearchAndMarkets.com | Business Wire [businesswire.com]
Ischemia Reperfusion Injury Pipeline Review, H2 2018 - Therapeutic Assessment of 24 Companies & Drug Profile Activity - ResearchAndMarkets.com | Business Wire [businesswire.com]
Pittsylvania County Joins the Fight Against the Opioid Industry: [prnewswire.com]
Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences | Business Wire [businesswire.com]
Paratek Pharmaceuticals Presenting New Omadacycline Data at IDWeek 2018 [globenewswire.com]
Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer [globenewswire.com]
Thinking about buying stock in Amarin Corporation, Facebook, General Electric, Netflix or Pandora? [prnewswire.com]
Mallinckrodt plc To Report Earnings Results For Third Quarter Of Fiscal 2018 [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
